Inventor · disambiguated record
Geoffrey S. Dow
Also filed as: DOW GEOFFREY · DOW GEOFFREY S · DOW GEOFFREY STUART
9 granted patents·9 pending applications·12 citations·filing 2006–2024
82Inventor score
Top patents by PatentIndex Score
18 records- 0188US11633391B2Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2021·Granted Apr 25, 2023·2 cites·47 claims
- 0285US10888558B2Regimens of tafenoquine for prevention of malaria in malaria-naive subjects60 DEGREES PHARMACEUTICALS LLC·Filed 2019·Granted Jan 12, 2021·3 cites·33 claims
- 0383US11744828B2Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects60 DEGREES PHARMACEUTICALS LLC·Filed 2021·Granted Sep 5, 2023·1 cites·10 claims
- 0479US10517854B2Dosing regiments of celgosivir for the treatment of dengue60 DEGREES PHARMACEUTICALS LLC·Filed 2017·Granted Dec 31, 2019·3 cites·20 claims
- 0577US2024082233A1Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects60 DEGREES PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 0675US9763921B2Dosing regimens of celgosivir for the treatment of dengue60 DEGREES PHARMACEUTICALS LLC·Filed 2014·Granted Sep 19, 2017·3 cites·66 claims
- 0774US2024390359A1Methods for the treatment and prevention of non-viral tick-borne diseases and symptoms thereof60 DEGREES PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0874US2025073222A1Methods for the treatment and prevention of non-viral tick-borne diseases and symptoms thereof60 DEGREES PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 0971US11369592B2Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitorsUNIV FLORIDA STATE RES FOUND·Filed 2021·Granted Jun 28, 2022·0 cites·20 claims
- 1069US2024408074A1Methods for the treatment and prevention of non-viral tick-borne diseases and symptoms thereof of60 DEGREES PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1167US12383546B2Methods for the treatment and prevention of lung infections caused by fungus by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2022·Granted Aug 12, 2025·0 cites·22 claims
- 1267US2022339140A1Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitorsUNIV FLORIDA STATE RES FOUND·Filed 2022·Application pending·0 cites
- 1364US2024226087A9Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1463US11219616B2Dosing regimens of celgosivir for the treatment of dengue60 DEGREES PHARMACEUTICALS LLC·Filed 2019·Granted Jan 11, 2022·0 cites·13 claims
- 1561US2024165099A1Methods for the treatment and prevention of diseases or infections with mcp-1 involvement by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1653US2022387419A1Methods for the treatment and prevention of lung infections caused by sars-cov-2 virus by administration of tafenoquine60 DEGREES PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1744US2011092488A1Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic InfectionsDOW GEOFFREY·Filed 2006·Application pending·0 cites
- 1833US11000516B2Dosing regimens of celgosivir for the prevention of dengue60 DEGREES PHARMACEUTICALS LLC·Filed 2016·Granted May 11, 2021·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Geoffrey S. Dow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →